Chemistry and Biochemistry Symposium to Feature NASA Speaker and Poster Session – Seton Hall University News & Events

Tuesday, April 11, 2017

By Nicholas Snow

The Department of Chemistry and Biochemistry is proud to present its 22nd annual departmental symposium and poster session in conjunction with the Petersheim Academic Exposition on Tuesday evening April 18, 2017.

The symposium will include a lecture in the Rose Mercadante Seminar Series by Dr. Melissa G. Trainer of the Robert Goddard Space Flight Center, National Aeronautics and Space Administration entitled "Chemistry on Mars: The Search for Habitable Environments with Curiosity" at 5:45 PM in the Helen Lerner Amphitheater, McNulty Hall, Science and Technology Center, Seton Hall University.

Following the lecture, a poster session featuring the research of 50 undergraduate and graduate students in the Department of Chemistry and Biochemistry will be held at 7:00 PM in the Mary Ann and Pat Murray Atrium in McNulty Hall. All members of the University Community and friends of the Department of Chemistry and Biochemistry are welcome to attend the lecture and poster session.

Following on decades of exploration of Mars, our knowledge of our neighboring planet has advanced well beyond observations of canals to the comprehensive characterization of surface topology and regional mineralogy. There are clear lines of evidence for past liquid water and a complex climate history. Yet some of the fundamental questions remain: Was there ever life on Mars? Could there have been life on Mars? The Curiosity rover carries the most advanced analytical laboratory sent to another planet, and over the past four and half years the mission has performed a detailed in situ investigation of Gale Crater. The Sample Analysis at Mars (SAM) instrument suite in particular has quantified geochemical indicators that demonstrate the environment could have supported life, and has achieved detection of the first organic molecules on Mars. Atmospheric measurements by SAM have identified signatures of planetary change over billions of years and monitored modern activity. This presentation will recount the most important findings on the chemistry of Mars to date, and will discuss the implications for our understanding of whether the red planet was ever habitable.

Dr. Trainer is a Research Space Scientist in the Planetary Environments Laboratory at NASA Goddard Space Flight Center, with research interests in the composition of planetary atmospheres and the production of organic organic molecules and aerosols via atmospheric synthesis.

Dr. Trainer has spent more than a decade characterizing the properties of Titan and early Earth aerosol analogs. Her publications on this topic include chemical, optical, and isotopic characterizations of these analogs produced via electric discharge and photochemical irradiation, with recent emphasis on the elemental composition, nitrogen activation, and the influence of trace species such as benzene.

Dr. Trainer is a science team member on the Sample Analysis at Mars (SAM) experiment aboard the Mars Science Laboratory Mission's Curiosity Rover, with a focus on the compositional measurements of the Mars atmosphere. She has led the campaign to conduct the first in situ multi-year study of the seasonal variations of the composition of the Mars atmosphere through surface mass spectrometry measurements. She also worked with the SAM team to make the first measurements of the full suite of xenon isotopes in the Mars atmosphere as well as the inventory of other noble gases.

The Department of Chemistry and Biochemistry offers BS, MS and PhD degrees with specializations in all areas of chemistry. Our unique research environment, including traditional full-time students and part-time students is designed to foster collaborations with industry and colleagues in other disciplines. The Rose Mercadante Seminar Series is named for Rose Mercadante, the departmental secretary for over 40 years, in honor of our alumni, her "boys and girls".

For more info: click here

Categories: Science and Technology

For more information, please contact:

Read the rest here:
Chemistry and Biochemistry Symposium to Feature NASA Speaker and Poster Session - Seton Hall University News & Events

Job Dekker receives inaugural International Award from British … – News from the University of Massachusetts

Job Dekker, PhD

Job Dekker, PhD, has been recognized by the Biochemical Society, based in London, as the inaugural recipient of the International Award. One of 11 eminent scientists honored overall by the Biochemical Society, Dr. Dekker, Howard Hughes Medical Institute investigator, professor of biochemistry & molecular pharmacology, and co-director of the Program in Systems Biology, was recognized for his distinguished and independent interdisciplinary research that illustrates the importance of the molecular biosciences in the advancement of life sciences research. Recipients of the International Award conduct research outside of the UK and Ireland and may be of any nationality.

I am extremely delighted to have been selected for this award, said Dekker. This really honors the work of my students, postdocs, collaborators and colleagues in this field that was started to uncover how cells fold their chromosomes.

Colin D Bingle, PhD, acting chair of the Biochemical Society award committee, said, The Biochemical Society awards are the perfect way to honor exceptional scientists within the bioscience community. As ever, the entry criteria are tough and the standards high and the awards are a real tribute to the talent within our community.

A pioneer in the study of the three-dimensional structure of the genome, Dekker developed the now widely used chromosome conformation technologies used to map the topography of the genome. Although DNA is comprised of a linear sequence of bases, it doesnt exist inside the cell nucleus in a simple, straight form. More like a ball of cooked spaghetti, the genome folds and loops back on itself so it can fit inside the tight confines of the nucleus. How the genome is packed inside the nucleus is tightly controlled and varies from cell type to cell type. And each unique shape has a profound influence on which genes in a cell are turned on or turned off.

Seeking tools and technology for mapping the three-dimensional structure of the genome in detail, Dekker developed a biochemical technique for determining how DNA segments interact and are linked to one another. The result, akin to a molecular microscope, can be used to detect physical interactions between DNA segments. The more interactions between segments, the more closely associated in space they are, due to chromosome folding. This breakthrough discovery was the genesis of what are now termed 3C, 5C and Hi-C tools, used by researchers worldwide interested in mapping the structure and organization of chromosomes inside cells.

Since joining UMMS, Dekker has refined and enhanced the initial chromosome conformation techniques to visualize whole genomes, combining it with next-generation sequencing to create high through put versions. A member of the UMMS faculty since 2003, Dekker received his doctoral degree in biochemistry from Utrecht University in the Netherlands. He trained as a postdoctoral fellow at Harvard University with Nancy Kleckner, PhD, studying chromosome structure and developing the techniques that led to the 3C technology.

Dekker was elected to the American Association for the Advancement of Science in 2014. In 2007, he was named a Keck Foundation Distinguished Young Scholar in Biomedical Research, and he received the 2011 Young Investigator Award from the American Society of Biochemistry and Molecular Biology.

The recipient of the International Award, which is new for 2018, will act as an ambassador for the Biochemical Societys international activities. The award aims to recognize the achievements of early to mid-career scientists who are within 20 years of PhD completion. Dekker is invited to deliver a lecture at the 24th International Union of Biochemistry and Molecular Biology/15th Federation of Asian and Oceanian Biochemists and Molecular Biologists Congress in Seoul, Korea, June 4 to 8, 2018, or at a society conference.

Related stories on UMassMedNow: Job Dekker explains DNA organization in New York Times article STAT: UMMS study of 3D genome may reveal hidden world of folding diseases Job Dekker becomes seventh Howard Hughes Medical Institute investigator at UMass Medical School Center for 3D Structure and Physics of the Genome established at UMMS

View post:
Job Dekker receives inaugural International Award from British ... - News from the University of Massachusetts

Doctor offers solution to biochem staff issue – Irish Examiner

A Dublin-based doctor has offered what he says is a solution to a staffing shortage at the biochemistry department in Cork University Hospital (CUH) which has led to the withdrawal of its clinical advisory service and a decision to voluntarily suspend accreditation.

Bill Tormey, a consultant chemical pathologist at Beaumont Hospital, said he and three colleagues are prepared to offer the clinical advisory service while CUH continues efforts to recruit consultant cover for the lab.

Professor Tormey said he is awaiting a response to his offer from the CEO of CUH. He said four chemical pathologists are willing, pro tem, to provide a comprehensive service to CUH.

His colleagues include Dr Vivion Crowley, biochemistry department, St James Hospital; Dr Gerard Boran of the School of Medicine, Trinity College Dublin and Dr Patrick Twomey, consultant chemical pathologist at St Vincents University Hospital.

Prof Tormey said by providing consultant cover, the lab would meet the requirements for accreditation. His offer would give CUH breathing space to continue its hunt for a new consultant following the retirement last year of biochemistry department chief, Dr John OMullane.

When asked about Prof Tormeys offer, a hospital spokesperson said they are looking at a number of options in relation to the provision of the service.

Prof Tormey said he is not offering a free service but would not be looking for agency rates.

Earlier this month, the HSE advertised for a locum consultant chemical pathologist. The hospital has said it is actively recruiting both a locum replacement and a permanent replacement but that as available candidates are not plentiful, it is difficult to put a timeframe on either competition.

A spokesperson said yesterday that a locum post was advertised pending the filling of the post on a permanent basis through the Public Appointments Service.

The hospital has advised GPs that its biochemistry department is currently unable to provide clinical advice and interpretation of lab results due to a lack of consultant cover.

The situation has also prompted the lab to seek voluntary suspension of its accreditation. Accreditation is an external, independent verification of the extent to which an organisation meets a pre-determined set of quality standards.

The hospital has said regardless of the lack of consultant cover, the same scientists will process patient specimens to a high quality standard, as before, and within the same timeframe. And while it cannot directly provide a clinical advisory service at this time, it can advise service users to seek appropriate advice from various other sources.

If a laboratory result appears to be discordant with the clinical situation, initial discussion with senior clinical laboratory personnel in biochemistry and/or with the patients consultant is warranted, it said.

The biochemistry department at CUH processed approximately eight million tests last year, including tests for liver function, renal function, cardiac function, hormones, and general chemistries.

Irish Examiner Ltd. All rights reserved

See the rest here:
Doctor offers solution to biochem staff issue - Irish Examiner

Grey’s Anatomy Star Camilla Luddington Gives Birth to a Baby Girl … – E! Online

Camilla Luddington has officially kicked off her newest rolemotherhood!

TheGrey's Anatomystar gave birth to a baby girl and confirmed the news to fans on Instagram with a black and white video of her and beauMatt Alanholding their little daughter outside. As a bonus, the actress also revealed their first child's name in the process.

"We have a new great love in our lives... our sweet baby girl...Hayden," she captioned the visual. In honor of the couple's new arrival, Luddington also accessorized with a fitting new braceleta delicate gold chain adorned with the letter "H." Picture perfect!

While the name feels like it was made just for the newborn, the new mom previously told E! News picking a moniker would come down to seeing their daughter for the first time."I think when we see the baby, we'll just know," she said in December.

By February, the ABC star revealed the baby's sex with a perfectly fitting nod to Lara Croft. "I am so excited to announce today that I am having a... girl!" she captioned a photo of herself holding a baby onesie with "Tomb Raider in Training" on it."I want her to grow up knowing how strong women are. To be a little warrior who is not afraid to use her voice and stand up for what she believes is right. To navigate through life with courage and kindness, and to be one of the girls who says 'you CAN sit with us...'"

Now, as Luddington navigates the world of motherhood, she has plenty of co-stars to swap advice with.

"I hear stories from all the moms on set," she told E! News at the 2017 People's Choice Awards. "So to have that experience myself, and all the joys and the highs and the lows, I'm excited for all of it."

Congratulations to the new mom and dad!

Read this article:
Grey's Anatomy Star Camilla Luddington Gives Birth to a Baby Girl ... - E! Online

Anatomy of a Goal: Nemanja Nikolic’s Game Winner – Massive Report

Welcome to Anatomy of a Goal, where each week we dissect one goal (or near goal) from the previous weeks Columbus Crew SC match.

For Week Six of the 2017 MLS Season, we take a look at Nemanja Nikolics 22nd minute one-timer that gave the Chicago Fire its only goal in a 1-0 win over Crew-SC on Saturday.

Heres a look at the finish from the Fire striker.

Columbus started this match in a new formation: A 4-3-3 with three central midfielders. Without the dynamic wide play of Harrison Afful, Crew SC defended much more narrowly than usual, here providing very little pressure on the Chicago offense.

Crew SC midfielder Wil Trapp and right back Hector Jimenez had just broken up a Bastian Schweinsteiger led attack.

Keep note of the (many) players highlighted. The movement and positioning of these players lead to the Fires game winner. Here, Schweinsteigers pass to Fire winger David Accam is headed back to midfield by Hector Jimenez. Immediately after this ball is played back, and picked up by Fire center-back Joao Meira. All of Chicagos players are in the Black & Gold half.

As soon as Meira picks up the ball, Accam heads out into a wide position, attracting the attention of a following Jimenez and opening up a channel between the fullback and Crew SC center-back Alex Crognale.

What these images will show is this goal is a result of Nikolic doing exactly what he is best at, running the channels. A channel, is any lane of space that exists between two defending players. In this circumstance, the channel that the Chicago goal scorer occupies is in the space between Crew SCs right back, Jimenez, and center-back, Crognale.

Once he receives the ball, Fire midfielder Dax McCarty can immediately see that Nikolic is in the channel created by Jimenez heading out to cover Accam. Here we can see that the Crew SC right back is in a tight spot, with three men to mark. Winger Ethan Finlay went to pressure the ball, leaving Accam, Brandon Vincent, and Nikolic all under the responsibility of Jimenez. Its tough to cast blame in this situation, but both Artur and Trapp stayed in the middle of the pitch rather than covering one of the three men left to the Crew SC right back. If Artur (or even Trapp) had attempted to track Vincent, then perhaps Jimenez has time to check Nikolic before he gets all the way in on goal.

The above image shows the channel between Jimenez and Crognale just after McCarty made his entry pass to Nikolic. In the middle of the balls journey to the Fire striker, this gap is about 12 yards wide. Jimenez has begun to chase Nikolic and Crognale is just now aware of the pass and the run by Chicagos forward.

One second later, the channel is still 10 yards wide. Nikolic;s run beat Jimenez, and Crognale makes a slightly arced run to cut off the strikers angle.

From this second angle, you can see just how much space Nikolic has and how much room Crognale has to cover. Though the Crew center backs route to the ball is direct, he hesitates just long enough that Nikolic is able to get a few steps on him.

Nikolic is now in the Crew SC box and has yet to touch the ball. The Fire striker is in the process of taking his first-touch shot at goal. In this image, pay attention to the positioning of Crognale and Columbus goalkeeper Zack Steffen. Steffen, expecting his center back to cut off the far post, positions himself to protect the near post. Crognale now has to decide if he will attempt to get in front of the ball with a stab, a slide, or if he is able to get his body in front of Nikolic.

Here, you can see just how close Crognale is to the ball and to Nikolic. With the angle he has taken, the Crew SC center back should be able to slide and either clear the ball out before he touches Nikolic, or give fellow center-back Nicolai Naess (who is just to the right out of this image) time to step in front of the Chicago attacker.

Instead of sliding, Crognale decides to stay on his feet. However, the Crew SC center back is neither able to get a foot or his body in front of Nikolics shot.

Nikolics first-touch shot catches Steffen, who is protecting his near post, on the wrong foot. Steffen is able to get a hand on the ball but is ultimately unable to stop the game winner from hitting the back of the net.

Findings:

See the rest here:
Anatomy of a Goal: Nemanja Nikolic's Game Winner - Massive Report

Program to focus on lung anatomy and basic medication – Newton Daily News

The Goodwill Career Connection Center, 600 N. Second Ave. W., Room 241 in Newton, is hosting a Lung Anatomy and Basic Medication event from 2 to 3 p.m. April 20.

The featured speaker will be Dr. Holly Melahoures. The program is presented by the CareMore Clinic, 1530 E. Euclid Ave. in Des Moines. Light refreshments and snacks will be provided.

Smoking is the leading cause of preventable death in the U.S., causing over 480,000 deaths per year. Secondhand smoke is a serious health hazard for people of all ages, causing more than 41,000 deaths each year. In 1987, lung cancer surpassed breast cancer as the leading cause of cancer deaths among women in the U.S. Among African-American high school students, cigars were the most commonly used tobacco product; among Hispanic high school students it was electronic cigarettes.

For more information about the American Lung Association of Iowa Better Breathers Club call 515-989-6001 or visit http://www.lung.org.

Read more:
Program to focus on lung anatomy and basic medication - Newton Daily News

Shonda Rhimes of ‘Grey’s Anatomy,’ ‘Scandal’ Fame Joins Planned Parenthood National Board – Breitbart News

SIGN UP FOR OUR NEWSLETTER

Rhimes said Planned Parenthood president and CEO Cecile Richards invited her to become a board member, according to Elle, which interviewed both women.

When someone you really admirecalls on you to serve, you say yes, Rhimes explained. The fact is that womens health is under fire right now. And so to me, it feels like its important to help fight back.

Richards observed Rhimes had been serving on the board of the Los Angeles Planned Parenthood affiliate.

She explained:

[W]hat she brings not only to this board, but frankly to the world, is her commitment to lift up the stories of people who dont always get heard, whether its in the way she talks about LGBT issues or womens reproductive health care or [the way she] centers people of color on television. To me, the most important work we can do now at Planned Parenthood is make sure that the voices of all those folks are heard, particularly in this political environment. And theres just no one better at utilizing the power of storytelling than Shonda Rhimes.

Rhimes said there wasnt a time that there wasnt a Planned Parenthood [available to me], though she added, And Im fortunate. Ive always had medical care. Ive always had access. Ive never personally had to use a Planned Parenthood.

Elle asked Rhimes why she believes womens spaces are so important.

[T]he idea that theres a place where you can go where everything is geared toward you, as a woman, is great, she said. But its a shame that we need to find places that are safe when the world, the whole world, should be a safe place. Its 2017, for Gods sakes. But because it needs to exist, Im glad that there is that space.

In November of 2015, Rhimess Scandal character Olivia Pope underwent an abortion while the Christmas hymn Silent Night played in the background. Following the abortion, Pope returned to the White House, where she sipped wine as Ave Maria played in the background.

Media Research Center called the Scandal episode an hour-long advertisement for Planned Parenthood.

[I]n this scene we were portraying amedical procedurethat is legal in the United States of America, Rhimes said. I wasnt sure what everybody was so concerned about. I was accurately portraying a medical procedure that the Supreme Court says people are allowed to have. I wasnt going to pull any punches.

Most people, I think, have accepted that its not up to them to control other peoples choices, except, it seems, when it comes to Washington, D.C., where everyone has an opinion about peoples uteruses, she added.

Richards said she hopes to channel the enormous creative energy and storytelling ability that Shonda Rhimes already has [in order] to do our work even better.

And she couldnt be joining us at a better time, she continued. When so much basic health care is under attack.

Follow this link:
Shonda Rhimes of 'Grey's Anatomy,' 'Scandal' Fame Joins Planned Parenthood National Board - Breitbart News

In search of a good Anthropocene? Physiology can help – OUPblog (blog)

It is generally accepted that the Earth has been irreversibly altered by an ever-growing human population. Indeed, we now refer to our current geologic period as the Anthropocene, to stress the great anthropogenic pressure on the planets atmosphere, geology, and biological diversity. In the face of threats such as habitat loss, pollution, and urban and agricultural expansion, it is easy to feel discouraged about the future prospect of the worlds ecosystems and biodiversity. However, scientists and conservationists have a choice about how to approach their mission to preserve existing habitats and rehabilitate those already in a state of degradation.

While much of the rhetoric surrounding the Anthropocene has been markedly negative, there has recently been a push by many scientists for a more positive narrative. Specifically, researchers are posing the question: can the Anthropocene be good? A good Anthropocene would balance the preservation of the natural world with realistic societal needs and consumption.

Recent research supports the value of a hopeful, rather than doom and gloom, perspective for rallying individuals to action. Messages of optimism are thought to be necessary to broadly engage the public and to attract youth to professional careers in the field of conservation biology. This makes intuitive senseif experts are constantly heard saying that all is lost, it is difficult to expect anyone to be motivated to change their behaviour.

The field of conservation biology is made up of a diversity of scientists and practitioners that use tools such as genetics, physiology, modelling, demographics, psychology, and social science. All of these branches have the capacity to contribute positive and progressive approaches to conservation science. Conservation physiology, one of the more recent, formally conceptualized sub-disciplines, is actively contributing to and proposing avenues for the good Anthropocene movement. Specifically, these pathways focus on taking a proactive approach to conservation, encouraging a pragmatic perspective when approaching conservation dilemmas, establishing an appreciation for environmental resilience, and being active in public outreach and policy-building. Establishing these four avenues as goals will allow conservation professionals to solve conservation problems through evidence-based conservation, better-populated models, an appreciation of the mechanisms underlying population declines, cross-disciplinary collaboration, and a well-informed public.

One example of how this multi-faceted approach can tackle a large-scale conservation problem is well-illustrated by research on clownfish (Amphiprion percula) in the Great Barrier Reef. Firstly, conservation physiology researchers are contributing to proactive conservation by applying knowledge of the respiratory physiology and microbiome of the fish to plan coastal development, determine vulnerability, predict how sediments from dredging may influence populations, and assess the potential for acclimation. The work is also underpinned by pragmatism. There is an appreciation that development is continuing and tactics are needed to diminish the associated impacts as much as possible. By taking an experimental approach aimed at determining threshold levels of suspended sediments that alter fish assemblage patterns, the timing of dredging can be sensitively adjusted to avoid interference with coral and reef fish spawning. As much of the work focuses on establishing thresholds, it also incorporates an appreciation of resilience and aims to determine when the capacity to cope with environmental change may be surpassed. Finally, researchers also made outreach a priority and took advantage of the publics familiarity with clownfish in Disneys Finding Nemo to garner attention about the impacts of habitat alteration on the respiratory health of these native fishes. As a whole, this physiological work has been contributing to evidence-based conservation and restoration plans that help to achieve a better Anthropocene.

Individuals trying to shine a positive light on the Anthropocene believe that leveraging technologies, knowledge, and passionate individuals can accomplish the tasks necessary to maintain nature in perpetuity. As we continue to develop new research foci, attempt to attract new students to our fields, and dedicate ourselves to the preservation of nature, we will do well to remember that conservation is ultimately an act of hope.

Featured image credit:Great Barrier Reef Marine Park. Great barrier reef by Wise Hok Wai Lum. CC BY-SA 4.0 via Wikimedia Commons.

Read more from the original source:
In search of a good Anthropocene? Physiology can help - OUPblog (blog)

The Q&A: Tyler Curiel – Texas Tribune

With each issue, Trib+Health brings you an interview with experts on issues related to health care. Here is this weeks subject:

Dr. Tyler Curielis a professor in the Department of Medicine and Department of Microbiology, Immunology and Molecular Genetics at the Joe R. & Teresa Lozano Long School of Medicine at the University of Texas Health Science Center at San Antonio. His areas of research focus on cancer immunotherapy and aging, among other things, and he was recently awarded a grant by the National Institute of Health to continue his cancer research.

Editors note: This interview has been edited for length and clarity.

Trib+Health: Can you expand on your recent findings in cancer immunology?

The Texas Tribune thanks its sponsors. Become one.

Tyler Curiel:After around 40 years of hard work from our group and other groups' parts, were seeing some real successes with immunotherapy for cancer. The big breakthrough came in understanding what the barriers were and overcoming those. One area where we have seen a rapid expansion of knowledge is in immune checkpoint blockade.

When you have a cancer or any type of insult on your body, it turns your immune system off. Cancers have figured out various off switches, and they give a signal to your immune response that the mission has been accomplished. We showed that you can make antibodies to block immune checkpoints your immune system has an off switch out there, and if we can prevent the off switch from doing what it's supposed to do, it can kill the cancer.

For the first time ever, we are starting to see patients with advanced-stage cancers responding to this checkpoint blockade kind of therapy.

Trib+Health:What are some problems you've encountered in the field?

Curiel: Although theres been really good success with this immune checkpoint strategy, the truth is that it only helps a minority of patients. The problem is most people dont respond, and the other thing is we are not good at predicting who will and wont respond.

The question is, how do these immune checkpoints work, and what are they really doing? If they work the way we think they will, then they should be working better, and we should be able to better predict who will and wont respond.

The Texas Tribune thanks its sponsors. Become one.

We have now shown that these immune checkpoint molecules have a lot of extra functions nobody knew about. There are inner signals inside tumor cells that give the cell additional instructions, including things like, "grow faster," "resist therapy," "spread to different parts of the body," and "attract cells to help turn the immune response off," among other things.

Now that we know this, it helps our understanding of who can and can't respond to therapy. We've conducted clinical trials with mice to help overcome new barriers and make this work better.

Trib+Health:What does your work in cancer immunotherapy look like now?

Curiel:We're now talking to biotech and pharma companies to develop new strategies for clinical trials so we can go out there and ask if what we found with mice will work with humans, too. Can we help explain why some people respond really well, but most not at all? We've done all of this in our mice.

Now we have to ask if we can do this in humans, and it looks like we can. That's what another big award from the National Cancer Institute is designed to do, and we are guardedly optimistic this will work.

Trib+Health:What are additional advancements you've made in the aging field, another area of your research?

Curiel:Most people probably don't recognize that the No. 1 risk factor for cancer is age it's not smoking or what you eat. It's no secret the U.S. and world are aging, and there's going to be a big uptick in cancer, just based on that fact.

Many colleagues have shown that immunotherapies that work really well in young people fail in old people. That's not a surprise, but the big surprise is we've been looking at the immune system, and when your immune system ages, the thought was everything works the way it used to work, it just doesn't work as well.

The Texas Tribune thanks its sponsors. Become one.

It turns out, that's not true. Some cells that didn't used to be there when you were young start appearing when you're old, and they do weird things we never knew about. And cells that were there when you were young, instead of doing less of what they used to do, do more of something that's bad for you.

Based on this, we developed the first therapy that's ever been described that will be effective as immunotherapy for cancer in aged mice but not young mice. We are able to understand what happens to the immune system when you age, and we developed therapies that are specific toward aged immune systems so that they will work when you are old and most at risk for cancer.

Trib+Health:Tell me about your presidential award you received in March.

Curiel:The presidential award is to recognize a lot of work from my lab over the last 10 years here at the Health Science Center that helped bring us to this particular point, but also other areas we are working on to improve cancer immunotherapy.

Meet Paige: Our new Facebook Messenger bot helps you keep track of the 85th Legislature. Subscribe by messaging HELLO to m.me/texastribune.org. Learn more.

Read the original post:
The Q&A: Tyler Curiel - Texas Tribune

New report: Global infectious immunology market forecasts to 2022 – WhaTech

New report onInfectious Immunologymarket is segmented based on types of diseases into HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases.

HBV affected nearly1.4 million in the U.S. in 2011. The rising incidence of these infectious diseases creates a worldwide demand for immunological diagnostics and treatment.

The infectious immunology market is segmented based on the types of products used for treatment such as diagnostic kits, instruments and reagents. Diagnostic kits hold the dominant share due to their effectiveness.

Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientifics, Bio-Rad Laboratories and Dr. Reddys Laboratories are the key players in the infectious immunology market.

Get Free Sample Report Of Infectious Immunology Market @bit.ly/2nJW6Ly

Infection involves an attack of disease-causing agents such as bacteria and viruses on the host organisms body that causes disturbances in normal functioning. Immunology is the study of the human bodys resistance to these infections.

The combined study ofinfections and immunologywould help authorities to handle infectious disease conditions including HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. The infectious immunology market comprises of the diagnosis and treatment of these infectious diseases with the help of antigen antibody reactions.

Key benefits

In-depth analysis of various regions would provide a clear understanding of current and future trends so that companies can make region specific plans Comprehensive analysis of the factors that drive and restrict the growth of the infectious immunology market is provided Key regulatory guidelines in various regions which impact the infectious immunology market are critically examined

Enquire Report Of Infectious Immunology Market @bit.ly/2p7Wtk5

...

The rest is here:
New report: Global infectious immunology market forecasts to 2022 - WhaTech